It’s been just revealed by more studies that those people who got a covid booster will not be needing one too soon. Check out the latest reports below.
People all over the world are considering the idea of living with the novel coronavirus. There are various viable vaccines that have been deployed so far and also more efficient treatments already – this led to more nations to get closer to saying that this pandemic is on the right path to becoming endemic. Check out the latest reports about covid boosters.
The latest reports note that people who have already gotten a covid booster will definitely not be needing one too soon.
The online publication mentioned above notes that three doses of a covid vaccine — or even just two — are enough to protect most people from serious illness and death for a long time, the studies suggest.
No more doses need soon
“We’re starting to see now diminishing returns on the number of additional doses.”
This is what John Wherry, director of the Institute for Immunology at the University of Pennsylvania, just said.
On the other hand, experts are saying that people who are over 65 or at high risk of illness may benefit from a fourth vaccine dose, it may be unnecessary for most people, he added.
Federal health officials including Dr. Anthony Fauci have also said that they are unlikely to recommend a fourth dose before the fall.
It’s been already revealed that the omicron variant can dodge antibodies produced after two doses of a covid vaccine.
“If people are exposed to another variant like omicron, they now got some extra ammunition to fight it.”
This is what Dr. Julie McElrath, an infectious disease physician and immunologist at Fred Hutchinson Cancer Research Center in Seattle said.
The same online publication mentioned above notes the fact that other parts of the immune system can remember and destroy the virus over many months if not years. The publication also mentions some studies that support this claim.
“Specialized immune cells called T cells produced after immunization by four brands of COVID vaccine — Pfizer-BioNTech, Moderna, Johnson & Johnson and Novavax — are about 80% as powerful against omicron as other variants, the research found.”
According to the reports, it is very likely that T cells would mount a similarly robust attack on any future variant as well, researchers said.
